SEOM clinical guideline on hereditary colorectal cancer (2019)
Identificadores
Identificadores
Visualización o descarga de ficheros
Visualización o descarga de ficheros
Fecha de publicación
2020Título de revista
Clinical & Translational Oncology
Tipo de contenido
Journal Article
DeCS
ensayos clínicos como asunto | proteínas de neoplasias | oncología médica | humanos | guías de práctica clínica como asunto | neoplasias colorrectalesMeSH
Clinical Trials as Topic | Humans | Neoplasm Proteins | Medical Oncology | Practice Guidelines as Topic | Colorectal NeoplasmsResumen
In the last 2 decades, clinical genetics on hereditary colorectal syndromes has shifted from just a molecular characterization of the different syndromes to the estimation of the individual risk of cancer and appropriate risk reduction strategies. In the last years, new specific therapies for some subgroups of patients have emerged as very effective alternatives. At the same time, germline multigene panel testing by next-generation sequencing (NGS) technology has become the new gold standard for molecular genetics.